Avi Kapoor
Surrozen
SRZN · NASDAQ
$25.14+$1.30 (+5.45%)TodayMarket closed ·
Prev close $23.84
About SRZN
- Employees
- 44
- Headquarters
- South San Francisco, California
- Listed
- Nov 23, 2020
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- surrozen.com
SRZN key statistics
- Market cap
- 295.48M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.20M
- Volume
- 323.90K
- Open price
- $23.74
- High today
- $25.45
- Low today
- $23.38
- 52 Week high
- $37.83
- 52 Week low
- $11.39
Surrozen (SRZN) at a glance
Surrozen (SRZN) last traded at $25.14, with a market cap of 295.48M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $23.38 and $25.45. The current price is 7.5% above the day's low and 1.2% below its high.
Volume so far is 323.90K shares, below the average of 1.20M shares a day.
Over the past year Surrozen has ranged from $11.39 to $37.83, and now sits 52% of the way up that range.
Surrozen met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.41 per share against an estimate of -$1.31.
The average analyst price target is $46.41, 84.6% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 4 analyst ratings say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 6 analystsAvg $46.41
- Low
- $40.40
- Now
- $25.14
- High
- $56.70
SRZN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 158.8% on average.
- Q3 FY24: reported -$0.44 per share against an estimate of -$2.51
- Q4 FY24: reported -$9.10 per share against an estimate of -$1.37
- Q1 FY25: reported -$7.43 per share against an estimate of -$1.82
- Q2 FY25: reported $2.55 per share against an estimate of -$1.13
- Q3 FY25: reported -$8.36 per share against an estimate of -$1.16
- Q4 FY25: reported -$14.03 per share against an estimate of -$1.21
- Q1 FY26: reported -$11.65 per share against an estimate of -$1.11
- Q2 FY26: reported -$0.41 per share against an estimate of -$1.31
SRZN news
- Avi Kapoor
Crude Oil Rises Over 4%; Darden Earnings Miss Views
- Vandana Singh
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
- Avi Kapoor
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Similar companies
Companies in the same industry as Surrozen
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.